DNAnexus
Private Company
Total funding raised: $256M
Overview
DNAnexus is a leading provider of a cloud-based data platform specifically designed for the precision health and genomics sector. Founded in 2009, the company offers an enterprise-grade solution that allows pharmaceutical companies, diagnostic providers, research institutions, and biobanks to securely manage, analyze, and derive insights from complex multiomic and clinical data at scale. The platform emphasizes regulatory compliance, AI integration, and operational efficiency, positioning DNAnexus as a critical infrastructure partner in the growing field of data-driven biomedical research. It is a private company trusted by major industry players to accelerate the translation of genomic data into scientific breakthroughs and improved patient outcomes.
Technology Platform
The DNAnexus Precision Health Data Cloud: A secure, compliant cloud platform for managing, analyzing, and collaborating on multimodal and multiomic data. It integrates workflow execution (Nextflow, WDL), AI/ML tools, cohort browsers, JupyterLab, and visualization apps within a framework compliant with GxP, HIPAA, GDPR, and other major regulations.
Funding History
5Opportunities
Risk Factors
Competitive Landscape
DNAnexus competes in the bioinformatics cloud platform space against broad cloud providers like AWS (Amazon Genomics CLI), Google Cloud (Life Sciences API), and Microsoft Azure (Azure Health Data Services) as well as other specialized players like Seven Bridges, Illumina's BaseSpace, and Partek Flow. Its differentiation lies in its deep focus on enterprise-grade security, pre-validated regulatory compliance, and a platform specifically architected for the end-to-end needs of precision health organizations.